Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

San Francisco-based firm introduces CardioLink Soy25, "a special blend of soy protein 25 grams," at PLMA trade show. The soy protein powder comes in vanilla and chocolate flavors and provides 100% of the daily value of vitamin E and 50 mg of soy isoflavones. Labeling carries FDA's approved health claim regarding soy protein and a reduced risk of coronary heart disease. Stores such as Walgreens, Long's Drugs and Osco-Savon have picked up the product; ads designed by Deerfield declaring Soy25 the "heart specialist" are slated to appear in January and February issues of magazines such as Ladies Home Journal, Redbook and Cooking Light

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts